Delivery Order SPE2DR25D3017-SPE2DR26F3ET0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Pioglitazone HCL 15 mg tablets in quantities of 500 units, with a ceiling value of $1,553.29 and an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Pioglitazone HCL 30 mg tablets in quantities of 500 units, with a ceiling value of $1,031.24. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-competitive set-aside contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Pioglitazone HCL 30 mg tablets (500 count) with a ceiling value of $5,361.80. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is scheduled for completion by November 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pioglitazone HCL 15 mg tablets (90-count units) with a ceiling value of $3,170.20. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 17,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,289.05 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (500-count package) on December 9, 2025, with completion scheduled for December 10, 2025. This contract utilized firm fixed-price pricing with no set-aside designation, indicating open competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,579.31 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 30 mg tablets (30-count packages) on November 13, 2025, with completion expected by November 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Pioglitazone HCL 30 mg tablets (90-count units) valued at $2,474.49. This non-competitive delivery order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a firm fixed-price transaction under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Pioglitazone HCL 30 mg tablets (500-count units) with a ceiling value of $1,680.77. This firm fixed price delivery order is scheduled for completion by December 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,663.37 to AmerisourceBergen Drug Corp for the supply of Pioglitazone HCL 15 mg tablets (90-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitively awarded delivery order procedures. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.41 to AmerisourceBergen Drug Corp for Pioglitazone HCL 30 mg tablets (90-count units) with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The place of performance is...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3ET0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Pioglitazone HCL 45 mg tablets (500 count) with a contract ceiling value of $3,637.83 and an ultimate completion date of December 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to fulfill federal medical procurement requirements across diverse therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/14/25 |